EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Resveratrol and atherosclerosis: A comprehensive review of its cardioprotective mechanisms and therapeutic potential

Razan Moghnieh, Mohammad Kheir Chahine, Riyad Mroweh, Nadim Chaarani, Issa Zalzali, Saleh-Yezan Abdulaal, Amer Yazbak, Hadi Farhat, Joy Raheb Khelo, Razan Abdulaal

Global Cardiology Science and Practice · 24.08.2025 · 2025 (4)

DOI: 10.21542/gcsp.2025.39 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Global Cardiology Science and Practice, online erschienen am 24.08.2025. Verfasst von Razan Moghnieh und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of Balamand, Faculty of Medicine and Medical Sciences, Dekwaneh, Beirut, Lebanon. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ardiovascular diseases (CVDs) remain a major global health issue, with atherosclerosis being a primary driver of their development. Atherosclerosis is driven by oxidative stress, chronic inflammation, and lipid dysregulation, which ultimately lead to endothelial dysfunction and plaque formation. Resveratrol, a polyphenolic compound found in grapes and red wine, has emerged as a promising therapeutic agent due to its multivalent protective effects against atherosclerosis. This review outlines the role of resveratrol in the inhibition of key pathologic processes, including suppression of pro-inflammatory signaling pathways, enhancement of antioxidant defense mechanisms, and regulation of cholesterol homeostasis. Resveratrol inhibits NF-κB activation, resulting in decreased vascular inflammation and reduced expression of adhesion molecules such as Vascular Cell Adhesion Molecule-1 (VCAM-1) and Intercellular Cell Adhesion Molecule-1 (ICAM-1), thereby preventing infiltration of immune cells into arterial vessels. Additionally, it increases cholesterol efflux by promoting ATP-binding cassette transporters (ABCA1), enhancing high-density lipoprotein (HDL) function, and lowering lipid levels. Evidence from preclinical and clinical studies suggests that resveratrol holds potential as a natural treatment for the prevention of atherosclerosis.

Autor:innen und Institutionen

  • University of Balamand, Faculty of Medicine and Medical Sciences, Dekwaneh, Beirut, Lebanon.
  • Beirut Arab University, Faculty of Medicine and Medical Sciences, Beirut, Lebanon.
  • Stadtkrankenhaus Korbach, Internal Medicine, Korbach, Germany.
  • Cleveland Clinic, Internal Medicine, Cleveland, Ohio, United States of America.

Zitieren

APA

Moghnieh, R., Chahine, M. K., Mroweh, R., Chaarani, N., Zalzali, I., Abdulaal, S. Y., Yazbak, A., Farhat, H., Khelo, J. R., & Abdulaal, R. (2025). Resveratrol and atherosclerosis: A comprehensive review of its cardioprotective mechanisms and therapeutic potential. Global Cardiology Science and Practice, 2025(4). https://doi.org/10.21542/gcsp.2025.39

Vancouver

Moghnieh R, Chahine MK, Mroweh R, Chaarani N, Zalzali I, Abdulaal SY, et al. Resveratrol and atherosclerosis: A comprehensive review of its cardioprotective mechanisms and therapeutic potential. Global Cardiology Science and Practice. 2025;2025(4). doi:10.21542/gcsp.2025.39

BibTeX
@article{Moghnieh2025,
  author = {Moghnieh, Razan and Chahine, Mohammad Kheir and Mroweh, Riyad and Chaarani, Nadim and Zalzali, Issa and Abdulaal, Saleh-Yezan and Yazbak, Amer and Farhat, Hadi and Khelo, Joy Raheb and Abdulaal, Razan},
  title = {Resveratrol and atherosclerosis: A comprehensive review of its cardioprotective mechanisms and therapeutic potential},
  journal = {Global Cardiology Science and Practice},
  year = {2025},
  volume = {2025},
  number = {4},
  doi = {10.21542/gcsp.2025.39}
}
Kostenlos starten →